Open AccessPreterm premature rupture of membranes: management between 28 and 34 weeks of pregnancy
Author(s) -
Isabela Cason,
Chayene Aguiar Rocha,
Rosely Erlach Goldman
Publication year - 2021
Publication title -
abcs health sciences
Language(s) - English
Resource type - Journals
eISSN - 2357-8114
pISSN - 2318-4965
DOI - 10.7322/abcshs.2020149.1600
Subject(s) - medicine , premature rupture of membranes , pregnancy , amniocentesis , obstetrics , fetus , medline , cochrane library , scielo , intensive care medicine , pediatrics , prenatal diagnosis , randomized controlled trial , surgery , genetics , political science , law , biology
Premature rupture of membranes remains a challenge for professionals due to the high rates of maternal and neonatal morbidity and mortality, mainly related to complications resulting from prematurity. Objective: To analyze the scientific production about premature rupture of membranes in pregnancies above 28 weeks and below 34 weeks. Methods: Integrative literature review carried out in the Lilacs, SciELO, Medline and Cochrane Library databases, between 2014 and 2018, in Portuguese, English and Spanish, including original articles, available in full online, with free access, that addressed the study theme, using the keywords "premature rupture of ovular membranes", "premature labor" and "pregnancy complications" combined using the Boolean operators "AND" and "OR". Results: Fourteen studies were included. It was possible to highlight the main recommendations regarding preterm premature rupture of membranes, divided into six categories for discussion, namely: indications for expectant management and delivery induction, prophylactic antibiotic therapy, prenatal corticosteroids, use of tocolytics, recommendations regarding the use of magnesium sulfate and amniocentesis. Conclusion: It was identified that expectant management is the ideal approach, with constant monitoring of the pregnant woman and the fetus, in addition to the administration of prophylactic antibiotics and prenatal corticosteroids, in the face of premature rupture of membranes in pregnancies between 28 and 34 weeks in order to provide the best maternal and perinatal results, guiding health professionals to evidence-based practice.